Most thyroid nodules don’t need treatment at all. Over 90% are benign, and many are simply monitored with periodic ultrasounds. When treatment is needed, the approach depends on whether the nodule is causing symptoms, producing excess hormones, or showing signs of cancer. Your options range from watchful waiting to minimally invasive procedures to surgery.
When Monitoring Is the Only Step
If a biopsy confirms your nodule is benign, the standard approach is regular ultrasound monitoring rather than any active treatment. Your first follow-up ultrasound typically happens 12 to 24 months after the initial biopsy. If the nodule hasn’t grown significantly at that point, the interval between scans can stretch to every three to five years.
Doctors define “significant growth” as a volume increase of more than 50%, or a 20% increase in at least two dimensions of the nodule. If your nodule hits those thresholds, your doctor will likely recommend a repeat biopsy rather than jumping straight to treatment.
Nodules that are mostly fluid-filled (cystic) or have a sponge-like appearance on ultrasound are considered very low risk. These can often be tracked with ultrasound every 12 to 24 months without ever needing a biopsy. Even small nodules with suspicious-looking features on ultrasound can sometimes be watched with scans every six to nine months, as long as there’s no sign they’re spreading beyond the thyroid or into nearby lymph nodes.
Why Thyroid Medication Usually Doesn’t Help
You may have heard that taking thyroid hormone pills can shrink nodules. This approach, called TSH suppression therapy, was once common, but current guidelines recommend against it for most people. The idea was to lower the hormone signal that tells the thyroid to grow, but nodule growth is driven by multiple factors beyond that single signal. In practice, meaningful shrinkage only happens in a minority of patients, typically those with small, recently diagnosed nodules.
The bigger issue is safety. Suppressing thyroid-stimulating hormone creates a state of mild thyroid overactivity, which raises the risk of bone loss in postmenopausal women and can worsen heart conditions or trigger irregular heart rhythms in older adults. For these reasons, this therapy is only considered in younger patients with specific circumstances, and doctors now routinely discontinue it in older patients who were started on it years ago.
Thermal Ablation for Symptomatic Nodules
If a benign nodule is large enough to cause pressure in your throat, difficulty swallowing, or a visible bulge, thermal ablation offers a way to shrink it without surgery. The two main options are radiofrequency ablation (RFA) and laser ablation (LA). Both use heat delivered through a thin needle to destroy nodule tissue, which the body then gradually reabsorbs.
In a head-to-head trial, RFA reduced nodule volume by 64% and laser ablation by 53% at six months. The proportion of patients achieving at least a 50% volume reduction was 87% with RFA compared to 67% with laser. Both procedures improved compression symptoms and cosmetic concerns by similar amounts. Broader clinical data from centers in Italy and South Korea show durable shrinkage of 50% to 80% after RFA.
These procedures take roughly 15 to 25 minutes and are performed with local anesthesia. Side effects are generally mild: temporary pain at the site, occasional bruising, and rare short-lived voice changes. A small number of patients experience a brief episode of thyroid overactivity afterward as the destroyed tissue releases stored hormone. The key advantage over surgery is that most of your thyroid gland stays intact, so you’re far less likely to need lifelong thyroid hormone replacement.
Ethanol Ablation for Fluid-Filled Nodules
Nodules that are mostly or entirely fluid-filled respond well to a different approach: ethanol injection. After draining the fluid with a needle, the doctor injects a small amount of alcohol into the collapsed cavity, which causes the walls to scar together and prevents refilling. Simple drainage alone has a recurrence rate of 60% to 90%, which is why the ethanol step matters.
Results are strong. In follow-up averaging two years, 89% of patients treated with ethanol ablation were free of symptoms, and 70% had at least a 50% reduction in nodule volume. The median volume decrease was about 76%. This is a straightforward office procedure and is generally the first-line option for cystic nodules that need treatment.
Radioactive Iodine for Overactive Nodules
Some nodules produce thyroid hormone on their own, independent of normal regulation. These “hot” nodules can cause hyperthyroidism, with symptoms like rapid heartbeat, weight loss, tremor, and heat intolerance. Radioactive iodine is the most common nonsurgical treatment for this problem.
You swallow a capsule or liquid containing a small dose of radioactive iodine, which concentrates in the overactive thyroid tissue and gradually destroys it. Thyroid levels don’t normalize immediately. It can take several months, and you may need medication in the interim to control symptoms. At the one-year mark, about 61% of patients have normal thyroid function, 11% remain mildly overactive (and may need a second dose), and 27% swing in the other direction and become hypothyroid, requiring daily thyroid hormone replacement going forward.
When Surgery Is Needed
Surgery becomes the recommended path in several situations: a solid nodule larger than 3 cm, a nodule causing airway or swallowing compression, a biopsy showing cancer or suspicious cells, rapid growth of a solid mass, or a cystic nodule that keeps refilling with fluid (or blood) after repeated drainage. Some patients also choose surgery because they simply want the nodule removed, regardless of its biopsy result, or for cosmetic reasons.
The two main operations are lobectomy (removing the half of the thyroid containing the nodule) and total thyroidectomy (removing the entire gland). For a single benign nodule, lobectomy is usually sufficient. If the nodule turns out to be cancerous on final pathology, a second surgery to remove the remaining half may be recommended. Some patients opt for total thyroidectomy upfront to avoid that possibility. After a lobectomy, the remaining half of the thyroid often produces enough hormone on its own. After total thyroidectomy, you will need to take thyroid hormone replacement daily for life.
The most discussed surgical risk is damage to the nerve that controls your vocal cords. In first-time thyroid surgery, permanent voice changes are uncommon, though the risk increases substantially in revision operations (reported rates range from under 1% to as high as 20% in reoperations). Temporary drops in calcium levels after surgery are also common, since the tiny parathyroid glands that regulate calcium sit directly behind the thyroid and can be bruised during the procedure. This usually resolves within weeks.
Treatment for Cancerous Nodules
If your biopsy reveals thyroid cancer, the treatment plan depends on the size and type. The most common thyroid cancers, papillary and follicular, have excellent survival rates.
For very small papillary cancers under 1 cm (called microcarcinomas), lobectomy alone is often sufficient. Studies show that the extent of surgery, whether removing half or all of the thyroid, does not affect recurrence rates or survival for these tiny cancers, as long as the tumor is confined to the thyroid and there’s no lymph node involvement or history of radiation exposure to the neck. Radioactive iodine therapy after surgery is not expected to improve outcomes for microcarcinomas.
Larger cancers, or those that have spread to lymph nodes, typically require total thyroidectomy followed by radioactive iodine to destroy any remaining thyroid tissue. Your doctor will then monitor you with blood tests and periodic imaging. The overall prognosis for differentiated thyroid cancer is very favorable, with most patients living normal lifespans.
Choosing the Right Approach
The decision tree for thyroid nodule treatment starts with two questions: is the nodule causing problems, and is there any concern about cancer? A small, benign, asymptomatic nodule needs nothing more than occasional ultrasound checks. A large benign nodule causing symptoms can often be managed with thermal ablation or ethanol injection, avoiding surgery entirely. Overactive nodules respond well to radioactive iodine. Surgery is reserved for the largest nodules, those with concerning biopsy results, or cases where less invasive options have failed or aren’t appropriate.
If you’ve been told you have a thyroid nodule, the single most important factor guiding your treatment is what the nodule looks like on ultrasound and, when needed, what the biopsy shows. Nodules that score low on the standardized ultrasound risk scale (called TI-RADS) may never need a biopsy at all. Even moderately suspicious nodules don’t typically require biopsy unless they’re at least 1.5 cm, and mildly suspicious ones can often be left alone until they reach 2.5 cm. Only the most suspicious-looking nodules trigger biopsy at the 1 cm threshold.